Patents by Inventor Jaroslaw Marek Mazurek

Jaroslaw Marek Mazurek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tenofovir Disoproxil Hemi-Fumaric Acid Co-Crystal
    Publication number: 20090270352
    Abstract: The present invention provides a novel crystalline form of Tenofovir disoproxil fumarate (Tenofovir DF), designated Co-crystal TDFA 2:1, methods for the preparation thereof and its use in pharmaceutical applications, in particular in anti-HIV medicaments. The crystalline form TDFA 2:1 can be used in combination with other anti-HIV medicaments such as Efavirenz, Emtricitabine, Ritonavir and/or TMC114.
    Type: Application
    Filed: May 21, 2008
    Publication date: October 29, 2009
    Applicant: ULTIMORPHIX TECHNOLOGIES B.V.
    Inventors: Evanthia Dova, Jaroslaw Marek Mazurek, Johnny Anker
  • Tenofovir Disoproxil Hemi-Fumaric Acid Co-Crystal
    Publication number: 20090176983
    Abstract: The present invention provides a novel crystalline form of Tenofovir disoproxil fumarate (Tenofovir DF), designated Co-crystal TDFA 2:1, methods for the preparation thereof and its use in pharmaceutical applications, in particular in anti-HIV medicaments. The crystalline form TDFA 2:1 can be used in combination with other anti-HIV medicaments such as Efavirenz, Emtricitabine, Ritonavir and/or TMC114.
    Type: Application
    Filed: December 1, 2008
    Publication date: July 9, 2009
    Applicant: ULTIMORPHIX TECHNOLOGIES B.V.
    Inventors: Evanthia Dova, Jaroslaw Marek Mazurek, Johnny Anker